We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$56.6B
AUM Growth
+$4.03B
Cap. Flow
+$1.92B
Cap. Flow %
3.4%
Top 10 Hldgs %
7.89%
Holding
3,713
New
414
Increased
1,834
Reduced
1,026
Closed
416

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$373M
2
COST icon
Costco
COST
+$283M
3
BMY icon
Bristol-Myers Squibb
BMY
+$270M
4
PFE icon
Pfizer
PFE
+$240M
5
MSFT icon
Microsoft
MSFT
+$225M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$274M
2
EMC
EMC CORPORATION
EMC
+$228M
3
GAS
AGL Resources Inc
GAS
+$216M
4
TE
TECO ENERGY INC
TE
+$136M
5
CHTR icon
Charter Communications
CHTR
+$133M

Sector Composition

Rank Sector Weight
1 Technology 15.61%
2 Healthcare 12.42%
3 Financials 11.99%
4 Consumer Staples 9.6%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCTH
3126
DELISTED
Delcath Systems Inc
DCTH
$148K ﹤0.01%
+59,914
New +$233K
PW
3127
Power REIT
PW
$2.93M
$147K ﹤0.01%
1,810
+290
+19% +$21.7K
ENLV icon
3128
Enlivex Ltd
ENLV
$28.4M
$146K ﹤0.01%
141
+101
+253% +$103K
AGRX
3129
DELISTED
Agile Therapeutics
AGRX
$144K ﹤0.01%
+10
New +$143K
NBSE
3130
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$143K ﹤0.01%
127
+72
+131% +$77.7K
FPP
3131
DELISTED
FieldPoint Petroleum Corporation
FPP
$142K ﹤0.01%
244,400
+900
+0.4% +$627
SJT
3132
San Juan Basin Royalty Trust
SJT
$129M
$141K ﹤0.01%
23,825
+8,700
+58% +$54.6K
QUOT
3133
DELISTED
Quotient Technology Inc
QUOT
$141K ﹤0.01%
+10,600
New +$141K
RVP icon
3134
Retractable Technologies
RVP
$20.3M
$138K ﹤0.01%
54,100
+9,000
+20% +$22.8K
ABAC
3135
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
$138K ﹤0.01%
71,275
+8,675
+14% +$24.2K
VII
3136
DELISTED
Vicon Industries, Inc.
VII
$137K ﹤0.01%
193,300
+59,600
+45% +$45.1K
LSTA icon
3137
Lisata Therapeutics
LSTA
$10.2M
$135K ﹤0.01%
1,943
+1,861
+2,270% +$150K
NTIP icon
3138
Network-1 Technologies
NTIP
$35.2M
$135K ﹤0.01%
49,600
+39,484
+390% +$106K
CIA icon
3139
Citizens
CIA
$198M
$134K ﹤0.01%
14,300
-22,800
-61% -$212K
DXTR
3140
DELISTED
Dextera Surgical Inc.
DXTR
$133K ﹤0.01%
70,672
+5,500
+8% +$11.7K
ACUR
3141
DELISTED
Acura Pharmaceuticals
ACUR
$131K ﹤0.01%
81,920
+6,300
+8% +$11.2K
DAC icon
3142
Danaos Corp
DAC
$2.56B
$130K ﹤0.01%
+3,464
New +$175K
XPL icon
3143
Solitario Resources
XPL
$73.9M
$130K ﹤0.01%
196,575
+55,975
+40% +$42.9K
JMP
3144
DELISTED
JMP Group LLC
JMP
$129K ﹤0.01%
23,333
+4,270
+22% +$23.8K
AMPE
3145
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$128K ﹤0.01%
+579
New +$162K
PTN
3146
Palatin Technologies
PTN
$17.8M
$126K ﹤0.01%
160
-14
-8% -$9.83K
HSTO
3147
DELISTED
Histogen Inc. Common Stock
HSTO
$125K ﹤0.01%
+313
New +$128K
MTL.PR
3148
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$124K ﹤0.01%
222,800
+1,900
+0.9% +$718
RNVA
3149
DELISTED
Rennova Health, Inc.
RNVA
$123K ﹤0.01%
1,448
+1,394
+2,581% +$183K
JASN
3150
DELISTED
Jason Industries, Inc.
JASN
$122K ﹤0.01%
55,000
+24,400
+80% +$67.5K
124 125
126
127 128

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's Q3 2016 Portfolio in Review

As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.

  • Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
  • Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
  • Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
  • Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
  • Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
  • Jim Simons opened 414 new positions and closed 416 in Q3 2016.
  • Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.